New drug AMG 133 put to the test: does it slow stomach emptying?
NCT ID NCT07429032
First seen Feb 25, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This early-phase study looked at how AMG 133, an experimental drug, affects how quickly the stomach empties in people who are overweight or have obesity. Researchers gave the drug or a placebo to 57 adults and measured stomach emptying using a special marker. The goal was to understand the drug's effects on digestion, not to treat or cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fortrea Clinical Research Unit - Daytona Beach
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.